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OBJECTIVES: Chondrolysis is defined as the rapid and diffuse loss of articular car-
tilage, typically within 12 months after surgery. Although described in nearly all
diarthroidial joints, recent studies have shown that chondrolysis has been misdi-
agnosed in numerous case reports. This study aimed to determine contributing
factors associated with the misdiagnosis of chondrolysis to help improve accurate
diagnostication and clinical decision making. METHODS: A systematic literature
review identified 128 publications on 783 joints (626 hips, 128 shoulders, and 29
knees) diagnosed as chondrolysis. Among these, 72 joints (48% knees, 9% shoul-
ders, and 7% hips) were determined to be misdiagnosed by consensus across five
orthopaedic surgeons. A broad range of data was examined in relation to misdiag-
nosis. For all cases, the presenting diagnosis and surgical procedure(s) as well as
other potential contributors including chemical, thermal, and mechanical factors
were examined to estimate the differential risk of rapidly developing osteoarthritis
which was categorized as low, moderate, or high. Descriptive statistics, bivariate
comparisons, and multivariate regression analyses were performed, with p0.05
denoting significance. RESULTS: Misdiagnosis of chondrolysis was neither associ-
ated with arthroscopic procedures nor chemical, thermal, or mechanical factors
during surgery. Among correctly diagnosed cases, the risk of developing rapid
osteoarthritis was considered low among 94.4% (671/711), moderate among 1.0%
(7/711), and high among 4.6% (33/711). In contrast, among misdiagnosed cases,
13.9% (10/72) of presenting diagnoses were considered low risk for osteoarthritis,
19.4% (14/72) moderate, and 66.7% (48/72) high. After adjusting for potential con-
founders, the single most significant predictor associated with misdiagnosis of
chondrolysis was a presenting medical condition that increased the risk of devel-
oping rapid osteoarthritis (p0.01). CONCLUSIONS: Misdiagnosis of chondrolysis
appears to be strongly correlated with the risk of rapidly developing osteoarthritis,
a pathology that is characterized by chronic and focal degeneration of cartilage
rather than rapid and diffuse cartilage loss that signify chondrolysis.
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OBJECTIVES:Correction of astigmatism during cataract surgery is important to free
the patient from distance vision spectacles. Several techniques are available: Laser,
Toric intraocular lenses and LRI. This abstract reports on the long term effective-
ness of LRI. METHODS: The charts of all patients having had LRI during cataract
surgery done by LG were extracted. The LRI consisted of a 6 mm length contra-
lateral limbal incision with a 600m depth calibrated lancet. The main outcome
was objective keratometry. Vector analysis was conducted according to Alpins and
Goggin. Success was defined as at least one diopter cylinder reduction in its axis
(/ 22.5°), independent of the pre-operative astigmatism (emmetropia was not
the objective). Keratometries performed before 3 months were not taken into ac-
count in the survival analyses (Kaplan-Meyer). RESULTS: A total of 129 eyes were
included in the analysis. Patients mean age was 68.3 and the sex ratio was 47 males:
53 females. Average follow-up was 2.0 years. On average, the cylinder was 1.8D (1.1)
before surgery and 1.4D (0.9) at one year. No major axis shift was observed on
average (from -1.6° at week 4 to 2.9° after 2 years) while its standard deviation was
high (from 73° at week 4 to 62° after 2 years). Success rates were 78% at week 50, 48%
at week 100 and 23% at week 250. CONCLUSIONS: A 6 mm length contra-lateral
limbal incision does not allow a 1D cylinder correction. The predictability of cor-
recting astigmatism along the cylinder axis is low. Consequently, the success rate
is low at week 50 and declining over the long term. The probability to be free of
distance vision glasses and to realize the associated savings is uncertain with LRI.
Lastly, interpreting effectiveness results of LRI based on vector analysis parameter
averages is misleading.
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OBJECTIVES: Evaluation of diagnostic, epidemiological, microbiological, surgical,
and economic parameters of periprosthetic hip and knee infections. METHODS:
Data of a large Berlin hospital group (5000 beds) were analysed over 3 years for the
above mentioned criteria. RESULTS: A total of 7524 arthroplasties from January 1,
2007 - December 2009 were performed because of femoral neck fractures and ar-
thritis of hip/knee; 18.1% of them were revisions, 319 of these (259 patients) due to
infection. All received major revision surgery; i.e. 208 patients underwent 1 revi-
sion, 43 patients 2, 7 patients 3, and 1 patient 4. Pathogen organisms were 57 x
coag-neg. Staphylococci, 54 x Staph. aureus, 21 x Enterococci, and 19 x Streptococci,
with a wide variety of further bacteria in fewer numbers. 72 SSI-infections were
multibacterial. MRSA was encountered 8 x. In 99 specimen bacteriology was neg-
ative. Most revisions were performed as two-stage procedures. Pre-op joint punc-
ture was carried out 92 x, with a positive result in 59 cases. Antibiotic treatment
was more effective, when pre-op bacterial diagnosis permitted a targeted drug
application. Age and ASA classification played no role in the prevalence of
periprosthetic infections. There were differences between hospitals, septic surgery
ranging from 4.5% up to 40.9% of all operative revisions (specialized departments).
Length and frequency of hospital stay were extended grossly, when infection oc-
curred, as well as the number of diagnostic and therapeutic measures. Besides the
individual disaster this resulted in a large increase in total cost for septic revision
surgery. CONCLUSIONS: Periprosthetic infections represent a catastrophe for the
patient, a burden for the therapeutic team and an economical hazard for society.
Methods to avoid this complication are high hygienic standards, early clinical de-
tection of infection, meticulous, repeated bacterial diagnostics, radical surgery,
and specific antibiotic treatment. The present study confirms these recommenda-
tions by analysis of 300 surgical revisions of alloarthroplastic infections.
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OBJECTIVES: To assess risks and benefits associated with AcrySof® Cachet
™
, other
marketed phakic intraocular lenses (PIOLs) in Europe, and laser refractive surgery
(RS) in patients with high myopia (HM). METHODS: MEDLINE, Embase, and Co-
chrane databases were searched for randomised controlled trials and observa-
tional studies conducted in HM patients. Two reviewers undertook data extraction
followed by reconciliation of included studies. Meta-analysis was performed to
combine comparative data; weighted means were calculated for single arm stud-
ies. The quality of single arm studies was assessed using Downs and Black checklist
(score 12: excellent quality). RESULTS: Of 1853 abstracts screened, 51 studies (23
comparative, 28 single arm studies) were included. Results were statistically sig-
nificant in favour (OR, 95% CI) of PIOLs compared to RS for manifest refractive
spherical equivalent (MRSE) within0.50D (3.42, 1.19–9.90), gain of1 lines of best
spectacles corrected visual acuity (BSCVA) (5.28, 1.26-21.97), and fewer secondary
refractive procedures (0.18, 0.10–0.33). Mean quality index score was 15.04. Base-
line characteristics including myopia severity and anterior chamber depth were
comparable across studies. AcrySof® Cachet™ showed favourable efficacy for un-
corrected distance visual acuity of 20/20 in 46.2% eyes at 3 years post-operative
(Artisan and Visian had 40.8% and 31.0% eyes respectively). Percentage of eyes
needing spectacles (criteria: MRSE not within 0.50D) were 43.45%, 17.19%, and
6.14% for Visian, Artisan, and AcrySof® Cachet™ respectively. For safety, the loss of
1 lines of BSCVA was 0.56% in AcrySof® Cachet™ and 2.25%, 13.16% for Artisan
and Visian respectively. Annualized post 6 month endothelial cell loss (0.41%) was
within the expected rate of natural loss (0.6%0.5%). CONCLUSIONS: PIOLs were
associated with proven favourable efficacy and safety compared to RS. Amongst
PIOLs, within the first 3 years AcrySof® Cachet™ has shown favourable efficacy and
safety. Comparative trials are required to confirm the robustness of results.
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OBJECTIVES: Surgical procedures may potentially interfere with anticancer drug
therapy for metastatic colorectal cancer (mCRC). The objective of this study was to
examine the proportion of patients with mCRC who underwent major surgeries.
METHODS: Using a large US medical claims database from a nationally commer-
cially-insured population, patients with diagnosed mCRC between January 2004
and March 2010 were identified. The first metastasis diagnosis date served as the
index date. Patients were followed from the index date to death, disenrollment, or
end of the study period, whichever occurred first. Major surgery was defined ac-
cording to the list of major surgeries developed by the National Committee for
Quality Assurance using Current Procedural Terminology procedure codes. Major
surgeries were examined by anatomic locations: 1) colon or rectum; 2) liver or lung;
and 3) all other anatomic sites. Major surgeries on colon or rectum were assessed
separately, since they likely include a high percentage of interventions to remove
primary tumors. The proportion of major surgeries was descriptively analyzed.
RESULTS: The study sample included 4768 mCRC patients who met the study
inclusion and exclusion criteria between January 2004 and March 2010. Mean age
was 60.0 years old and 45.9% of patients were female. Mean length of follow-up
observation period was over one year (414 days). Overall, 42.3% of patients had at
least one major surgery on anatomic sites other than colon/rectum after mCRC
diagnosis. By anatomic locations, 17.6% of patients had major surgeries on liver or
lung (13.4% on liver and 4.9% on lung); and 32.3% had major surgeries on all other
anatomic sites. Major surgeries on colon or rectum occurred in 35.9% of patients
(32.9% on colon and 4.1% on rectum). CONCLUSIONS: Major surgeries are highly
prevalent in patients with mCRC from this commercially insured population after
mCRC diagnosis. This might have implications for anticancer drug therapy in
mCRC patients.
Surgery – Cost Studies
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OBJECTIVES: Costs related to Magnetic Resonance Guided Focused Ultrasound
(MR-HIFU) for uterine fibroids have not been compared to alternative treatments
being performed in Germany up to now. Hence, the purpose of this analysis was to
identify the cost-consequences of hysterectomy, myomectomy, uterine artery em-
bolization (UAE) and MR-HIFU in the first year of therapy. In addtition the budget
impact of the MR-HIFU from the perspective of the NHS (direct costs) and social
perspective (indirect costs) should be analysed.METHODS:The cost of leiomyoma-
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related hospitalization and patient follow-up was calculated based on data from
statistics of the Hospital Remuneration System, the G-DRG hospital payment
scheme and the office-based doctors’ fee scale. The cost caused due to recovery and
disability was estimated based on information from the Federal Statistical Office
and data of the Federal Health Reporting. Experts were interviewed to provide
follow-up resource use information. RESULTS: A total of 78,229 hospitalized leio-
myoma-related cases were treated in year 2009. 80% were hysterectomies, 14%
myomectomies and 6% were related to other therapies. Concerning the therapy
cost per patient, hysterectomy reveals the highest therapy cost, (€5913) followed by
myomectomy (€5793), UAE (€4675) and MR-HIFU (€4311). In a scenario without MR-
HIFU the cost per case accrued to a total of €5840. The budget impact analyse
targeting a patient group between 30 and 45 years of age, reveals a potential cost-
benefit of €1529 per patient if MR-HIFU would be introduced in the SHI system.
CONCLUSIONS: Our results suggest that MR-HIFU due to the administration in the
outpatient sector, the low complication rate and the low disability cost should be
considered as a cost-favourable alternative for the therapy of uterine fibroids.
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OBJECTIVES: The aim of this study was to assess the clinical and economic impact
of malnutrition in post-surgery colorectal cancer patients. METHODS: We per-
formed post-hoc analyses of the data collected in the Alves and al* prospective
study. The following criteria for malnutrition were used: weight loss10% in the 6
months pre-surgery and/or BMI18.5 (pts 70 years) or 21 (pts 70 years). 2
groups (gps) were created a posteriori: Well-Nourished (WN) and Malnourished
(MN) pts. Postoperative morbidity, mortality, hospital length-of-stay (LOS), and
hospital discharge setting were compared between the 2 gps. Individual costs were
valued using the French National Cost Study. We defined 3 scenarios: the most
accurate estimate and the upper and lower possible limits of this estimate. The
economic impact of malnutrition was assessed by calculating the difference in cost
per hospital stay between MN and WN pts. RESULTS: A total of 762 pts were in-
cluded in the analyses. Gps had the same characteristics, except more MN pts
underwent emergent surgery. Complication rate was not significantly different
between the 2 gps; mortality was higher in MN pts (7.4% vs. 4.1%, p0.056) and MN
pts had a mean LOS 3.1 days longer than WN pts (p0.004). A greater proportion of
MN pts could not be discharged and were referred to another facility (69.6% vs.
54.2%, p0.027). Malnutrition impacts the cost per hospital stay by about 3154€ per
patient (most accurate estimate), creating an annual impact of 9,572,770€ for
French public hospitals. CONCLUSIONS: Malnutrition in colorectal cancer surgical
pts is associated with a significant increase of LOS and delays returning home
following hospitalization; both have significant budget impact. Prospective studies
are needed to further investigate this impact and related cost-benefit of (special-
ized) nutritional support in this homogeneous category of patients.
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OBJECTIVES: To examine real world health care utilization (HCU) and costs asso-
ciated with whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS)
as the initial or only treatment of brain metastasis (BrMets). METHODS: A retro-
spective longitudinal analysis utilized claims data from a national health insurer,
identifying patients18 yrs with2 claims7 days apart for BrMets (ICD-9 198.3x)
from 1/2004-4/2010. The index date was first BrMts claim date. Pre-index period of
6 months and 1 month post-index enrollment (1 month was permitted if due
to death). Patients with primary brain cancers were excluded. HCU and all-cause
per-patient per-month (PPPM) costs were examined. RESULTS: The study included
1,901 and 303 patients who received WBRT or SRS as first or only treatment, with
179d vs. 306d follow-up, respectively. Baseline Charlson comorbidity scores were
similar. Mean age at BrMets diagnosis was higher for WBRT (59yrs) vs. SRS (57yr)
[p-value0.002]. Rates of HCU (events/person-month) were higher among WBRT
vs. SRS patients for office visits (5.29 vs. 3.69), ER visits (0.25 vs. 0.17), and inpatient
stays (0.26 vs. 0.17); rates of outpatient visits were lower among WBRT patients
(2.31 vs. 3.24) [p-value0.001]. Total costs PPPM were higher for the SRS ($20,682) vs.
WBRT cohort ($16,909) [p-value0.005]. Outpatient costs PPPM was the major cost-
driver among the SRS cohort ($8,936, 43% of total) vs. $3,192 (19% of total) for WBRT.
Office costs PPPM contributed most to overall cost among WBRT ($3,428, 20% of
total) vs. $3,053 (18% of total) for SRS. Pharmacy costs PPPM were higher for the SRS
($1,232) vs. WBRT cohort ($692) [p-value 0.001]. CONCLUSIONS: BrMets patients
with SRS incurred higher cost compared to WBRT patients. SRS is recommended
for BrMets patients with 3 lesions and WBRT in 3 lesions may explain longer
survival among SRS patients. Additional studies are augmented to understand
differences.
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OBJECTIVES: To estimate the healthcare resource utilization and their associated
costs secondary to fasciectomy of Dupuytren=s disease treated according with
usual medical practice in public hospital centers in Spain. METHODS: This multi-
center, observational, retrospective cohort study, extracted data through the revi-
sion of medical records of three tertiary public hospitals. Each center should recruit
40 patients which were operated for Dupuytren=s disease, as principal diagnose of
Minimum Data Set, in which the surgical procedure conducted was fasciectomy,
during 2007-2009. To collect all the resources consumed during surgery, a health-
care resource utilization form was designed. Demographic (age, gender, occupa-
tional status), clinical (time of evolution of the pathology and comorbilities) and
healthcare utilization (hospitalizations, medical visits, test, and drugs) data were
collected under medical routine. Unitary costs were provided by e-SALUD and BOT
data base. RESULTS:A total of 123 subjects (86.2% men; 35.8% active workers) were
identified. 17.8% of subjects were diagnose of Dupuytren before year 2000; 8.4%
between 2000-2005 and 73.8% after 2006. 81.3% of patients had at least one comor-
bidity, being hypertension (45%) the most frequent. 71.6% of patients were hospi-
talized in orthopedist (75%) and plastic surgery unit. Mean(SD) length of hospital
stay was 1.5(1.1) days. 28.4% there were operated in ambulatory surgery. All the
patients had follow-up visits after surgery, 27% needed physical therapy, 88% per-
formed preoperative tests and 8% visit the emergency room after surgery. Health-
care mean costs were as follows: fasciectomy €1074(0); hospitalizations €978(743);
ambulatory €186(10); follow-up visits €260(173); emergency rooms €13(53); tests
€132(121); drugs €7(9); physical therapy €46(134). Total cost for patients with Du-
puytren’s disease treated with surgery was €2304(825). There were no significant
differences between the three centers analyzed; p0.181. CONCLUSIONS: This
evaluation suggest that healthcare resources utilization for surgical treatment for
patients with Dupuytren’s disease may cost €2,304(825) per surgery (fasciectomy)
treated under usual medical practice in Spain.
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OBJECTIVES: To examine changes in post-tubal ligation complications and their
associated costs over time.METHODS:Data were obtained from the US i3 Invision™
Data Mart. Data collected spanned the period from January, 2006 through March,
2010. CPT and ICD-9 codes were used to identify patients who received a tubal
ligation as well as a post-tubal ligation complication. Patients were also subcate-
gorized based upon year of tubal ligation (2007, 2008, or 2009) in order to examine if
there were any noticeable trends over time. RESULTS: There were 15,169 women
under age 50 who received a tubal ligation and had continuous insurance coverage
in the 1 year post-tubal ligation. The mean age at tubal ligation was 35.26 years
(SD5.46) with 10.46% having tubal ligation at the time of a pregnancy. Overall,
21.68% (n3,288) of women experienced at least 1 complication, with the most
common being heavy menstrual bleeding (n2,190, 14.44%) and surgical compli-
cations (n729, 4.81%). When assessing changes in complications from 2007-2009,
diagnoses of heavy menstrual bleeding (p0.0003), sepsis (p0.0392), surgical com-
plications (p0.0240), and any complication (p0.0001) all showed statistically sig-
nificant increases over time. Of all women who had a tubal ligation, charges asso-
ciated with the tubal ligation did not increase significantly from 2007-2009;
however, the charge associated with complications did show a statistically signif-
icant increase over the same time period. The average charge for women who
experienced a complication (n3,228) was $37,425 (SD$68,249). CONCLUSIONS:A
substantial number of women experience post-tubal ligation complications and
the charges associated with these complications have increased significantly over
time.
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OBJECTIVES: There are limited data currently available regarding the prevalence of
post-transplant events and associated resource utilization in renal transplant pa-
tients in clinical practice. This study aims to describe the healthcare resource
utilization and costs of managing patients after renal transplantation, stratified by
relative graft functioning status, using observational data from relevant databases
and physician questionnaires from transplant centres across Europe. METHODS:
Data from renal databases in Cardiff and Leuven University Hospitals have been
analysed to assess 3-year post-transplant resource use in the UK and Belgium,
respectively. Similar data have been derived from questionnaires administered in
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